Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Loganathan, Sivakkanan [VerfasserIn]   i
 Korkmaz-İçöz, Sevil [VerfasserIn]   i
 Radovits, Tamás [VerfasserIn]   i
 Li, Shiliang [VerfasserIn]   i
 Mikles, Beatrice [VerfasserIn]   i
 Barnucz, Enikő [VerfasserIn]   i
 Hirschberg, Kristóf [VerfasserIn]   i
 Karck, Matthias [VerfasserIn]   i
 Szabó, Gábor [VerfasserIn]   i
Titel:Effects of soluble guanylate cyclase activation on heart transplantation in a rat model
Verf.angabe:Sivakkanan Loganathan, MD, Sevil Korkmaz-Icöz, PhD, Tamás Radovits, MD, PhD, Shiliang Li, MD, Beatrice Mikles, EnikőBarnucz, MD, Kristóf Hirschberg, MD, PhD, Matthias Karck, MD, and Gábor Szabó, MD, PhD
E-Jahr:2015
Jahr:11 June 2015
Umfang:8 S.
Fussnoten:Gesehen am 02.06.2020
Titel Quelle:Enthalten in: The journal of heart and lung transplantation
Ort Quelle:Amsterdam [u.a.] : Elsevier Science, 1999
Jahr Quelle:2015
Band/Heft Quelle:34(2015), 10, Seite 1346-1353
ISSN Quelle:1557-3117
Abstract:Background - The nitric oxide (NO)/soluble guanylate cyclase (sGC)/cyclic guanosine monophosphate (cGMP) pathway is an important key mechanism to protect the heart from ischemia/reperfusion injury. However, this pathway is disrupted in several cardiovascular diseases as a result of decreased NO bioavailability and increased NO-insensitive forms of sGC. Cinaciguat preferentially activates these NO-insensitive, oxidized forms of sGC. - Methods - We assessed the hypothesis that targeting NO-unresponsive sGC would protect the graft against ischemia/reperfusion injury in a rat heart transplantation model. Before explantation, donor Lewis rats received methylcellulose (1%) vehicle or cinaciguat 10 mg/kg. The hearts were excised, stored in cold preservation solution, and heterotopically transplanted. We evaluated in vivo left ventricular function of the graft. - Results - After transplantation, decreased left ventricular systolic pressure (77 ± 3 mm Hg vs 123 ± 13 mm Hg, p < 0.05), dP/dtmax (1,703 ± 162 mm Hg vs 3,350 ± 444 mm Hg, p < 0.05), and dP/dtmin (995 ± 110 mm Hg vs 1,925 ± 332 mm Hg, p < 0.05) were significantly increased by cinaciguat. Coronary blood flow was significantly higher in the cinaciguat group compared with the control group. Additionally, cinaciguat increased adenosine triphosphate levels (1.9 ± 0.4 µmol/g vs 6.6 ± 0.8 µmol/g, p < 0.05) and improved energy charge potential. After transplantation, increased c-jun messenger RNA expression was downregulated, whereas superoxide dismutase-1 and cytochrome-c oxidase mRNA levels were upregulated by cinaciguat. Cinaciguat also significantly decreased myocardial DNA strand breaks induced by ischemia/reperfusion during transplantation and reduced death of cardiomyocytes in a cellular model of oxidative stress. - Conclusions - By interacting with NO-unresponsive sGC, cinaciguat enhances the protective effects of the NO/cGMP pathway at different steps of signal transduction after global myocardial ischemia/reperfusion. Its clinical use as pre-conditioning agent could be a novel approach in cardiac surgery.
DOI:doi:10.1016/j.healun.2015.05.006
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext ; Verlag: https://doi.org/10.1016/j.healun.2015.05.006
 Volltext: http://www.sciencedirect.com/science/article/pii/S1053249815012772
 DOI: https://doi.org/10.1016/j.healun.2015.05.006
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:cinaciguat
 heart transplantation
 ischemia/reperfusion
 nitric oxide
 soluble guanylate cyclase
 soluble guanylate cyclase activation
K10plus-PPN:1699158355
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68582559   QR-Code
zum Seitenanfang